Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer - PubMed (original) (raw)
. 2004 May 1;109(5):717-20.
doi: 10.1002/ijc.20034.
Affiliations
- PMID: 14999780
- DOI: 10.1002/ijc.20034
Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer
David Agudo et al. Int J Cancer. 2004.
Abstract
The nuclear pore complex protein Nup88 is overexpressed in tumor cells. Immunohistochemical studies have shown that this overexpression is linked to higher aggressiveness of colorectal carcinoma and to enhanced metastatic potential of melanoma cells. However, the antibodies so far developed against Nup88 have the drawback of recognizing a number of other, up to now unspecified antigens besides Nup88. For this reason, we devised the present study on Nup88 expression at the mRNA level. RNA was extracted from fresh tumor tissue corresponding to 122 breast cancer patients. Nup88 mRNA expression was measured by means of differential RT-PCR, standardizing against a constitutive internal control gene (beta-actin). The results were dichotomized into "high" and "low" expression levels, using the median value as cut-off. High Nup88 mRNA expression levels correlated significantly with ductal and tubular histology (p = 0.012), histologic and nuclear grade 3 of tumors (p < 0.001), absence of hormone receptor expression (p < 0.001), expression of the c-erb-B2 oncogene (p < 0.001), expression of mutant p53 protein (p < 0.001), high proliferation (defined by Ki67 labeling index >20%, p < 0.001), DNA aneuploidy (p < 0.001) as well as the most important ominous clinical prognostic factor, axillary node invasion (p < 0.001). We also found an inverse correlation (p < 0.001) with expression of the H-MAM (mammaglobin) gene, a marker of low biologic and clinical aggressiveness of breast cancer. All of these factors, without exception, define a highly aggressive tumor phenotype. These findings appear to be specific to Nup88 and not to nuclear pore proteins in general. Indeed, analysis of Nup107 (which is a limiting component of the nuclear pore complex) under the same conditions in the same tumors did not yield comparable results.
Copyright 2004 Wiley-Liss, Inc.
Similar articles
- Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype.
Núñez-Villar MJ, Martínez-Arribas F, Pollán M, Lucas AR, Sánchez J, Tejerina A, Schneider J. Núñez-Villar MJ, et al. Breast Cancer Res. 2003;5(3):R65-70. doi: 10.1186/bcr587. Epub 2003 Mar 6. Breast Cancer Res. 2003. PMID: 12793902 Free PMC article. - Relationship between mammaglobin expression and estrogen receptor status in breast tumors.
Guan XF, Hamedani MK, Adeyinka A, Walker C, Kemp A, Murphy LC, Watson PH, Leygue E. Guan XF, et al. Endocrine. 2003 Aug;21(3):245-50. doi: 10.1385/ENDO:21:3:245. Endocrine. 2003. PMID: 14515009 - Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women.
Temmim L, Baker H, Sinowatz F. Temmim L, et al. Anticancer Res. 2001 Jan-Feb;21(1B):743-8. Anticancer Res. 2001. PMID: 11299837 - Biological markers of invasive breast cancer.
Matsumoto A, Jinno H, Ando T, Fujii T, Nakamura T, Saito J, Takahashi M, Hayashida T, Kitagawa Y. Matsumoto A, et al. Jpn J Clin Oncol. 2016 Feb;46(2):99-105. doi: 10.1093/jjco/hyv153. Epub 2015 Oct 20. Jpn J Clin Oncol. 2016. PMID: 26486826 Review. - Neu (c-erbB-2), a tumor marker in carcinoma of the female breast.
Maguire HC Jr, Greene MI. Maguire HC Jr, et al. Pathobiology. 1990;58(6):297-303. doi: 10.1159/000163601. Pathobiology. 1990. PMID: 1981830 Review.
Cited by
- Increased serum level of Nup88 protein is associated with the development of colorectal cancer.
Zhao ZR, Zhang LJ, Wang YY, Li F, Wang MW, Sun XF. Zhao ZR, et al. Med Oncol. 2012 Sep;29(3):1789-95. doi: 10.1007/s12032-011-0047-1. Epub 2011 Aug 24. Med Oncol. 2012. PMID: 21863385 - The role of vimentin in the tumor marker Nup88-dependent multinucleated phenotype.
Makise M, Nakamura H, Kuniyasu A. Makise M, et al. BMC Cancer. 2018 May 3;18(1):519. doi: 10.1186/s12885-018-4454-y. BMC Cancer. 2018. PMID: 29724197 Free PMC article. - Assessment of the axilla in women with early-stage breast cancer undergoing primary surgery: a review.
James J, Law M, Sengupta S, Saunders C. James J, et al. World J Surg Oncol. 2024 May 9;22(1):127. doi: 10.1186/s12957-024-03394-6. World J Surg Oncol. 2024. PMID: 38725006 Free PMC article. Review. - Nucleoporin 88 expression in hepatitis B and C virus-related liver diseases.
Knoess M, Kurz AK, Goreva O, Bektas N, Breuhahn K, Odenthal M, Schirmacher P, Dienes HP, Bock CT, Zentgraf H, zur Hausen A. Knoess M, et al. World J Gastroenterol. 2006 Sep 28;12(36):5870-4. doi: 10.3748/wjg.v12.i36.5870. World J Gastroenterol. 2006. PMID: 17007055 Free PMC article. - Oncogenic potential of nucleoporins in non-hematological cancers: recent update beyond chromosome translocation and gene fusion.
Roy A, Narayan G. Roy A, et al. J Cancer Res Clin Oncol. 2019 Dec;145(12):2901-2910. doi: 10.1007/s00432-019-03063-2. Epub 2019 Oct 25. J Cancer Res Clin Oncol. 2019. PMID: 31654122 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous